Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MARK2 ELISA Kit

MARK2 Reactivity: Human Colorimetric Sandwich ELISA 0.313 ng/mL - 20 ng/mL Plasma, Serum
Catalog No. ABIN6219503
  • Target See all MARK2 products
    MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
    Reactivity
    Human
    Detection Method
    Colorimetric
    Method Type
    Sandwich ELISA
    Detection Range
    0.313 ng/mL - 20 ng/mL
    Minimum Detection Limit
    0.313 ng/mL
    Application
    ELISA
    Purpose
    Human MARK2 ELISA Kit is an ELISA Kit against MARK2.
    Sample Type
    Plasma, Serum
    Analytical Method
    Quantitative
    Sensitivity
    < 0.188 ng/mL
  • Application Notes

    Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

    Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

    Standard Form: Lyophilized

    Plate
    Pre-coated
    Restrictions
    For Research Use only
  • Storage
    4 °C/-20 °C
    Storage Comment
    Upon receipt, store the kit according to the storage instruction in the kit's manual.
    Expiry Date
    6 months
  • Target See all MARK2 products
    MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
    Alternative Name
    MARK2 (MARK2 Products)
    Synonyms
    EMK-1 ELISA Kit, EMK1 ELISA Kit, PAR-1 ELISA Kit, Par-1b ELISA Kit, Par1b ELISA Kit, AU024026 ELISA Kit, Emk ELISA Kit, Par-1 ELISA Kit, mKIAA4207 ELISA Kit, microtubule affinity regulating kinase 2 ELISA Kit, MAP/microtubule affinity regulating kinase 2 ELISA Kit, MARK2 ELISA Kit, Mark2 ELISA Kit
    UniProt
    Q7KZI7
    Pathways
    SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here:
Support